- Home
- MTG vs PCVX Comparison
MTG vs PCVX Comparison
Compare MTG & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MTG | PCVX |
|---|---|---|
| Founded | 1957 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 6.1B |
| IPO Year | 1991 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MTG | PCVX |
|---|---|---|
| Price | $28.75 | $46.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $28.00 | ★ $105.00 |
| AVG Volume (30 Days) | ★ 1.8M | 1.3M |
| Earning Date | 02-02-2026 | 02-24-2026 |
| Dividend Yield | ★ 2.07% | N/A |
| EPS Growth | ★ 9.77 | N/A |
| EPS | ★ 3.11 | N/A |
| Revenue | ★ $1,216,428,000.00 | N/A |
| Revenue This Year | $2.34 | N/A |
| Revenue Next Year | $3.07 | N/A |
| P/E Ratio | $9.33 | ★ N/A |
| Revenue Growth | ★ 2.20 | N/A |
| 52 Week Low | $21.94 | $27.66 |
| 52 Week High | $29.97 | $93.77 |
Technical Indicators
Market Signals| Indicator | MTG | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 45.07 | 49.59 |
| Support Level | $28.82 | $43.95 |
| Resistance Level | $29.79 | $47.76 |
| Average True Range (ATR) | 0.47 | 1.83 |
| MACD | -0.12 | -0.11 |
| Stochastic Oscillator | 3.46 | 52.65 |
Price Performance
Historical ComparisonAbout MTG MGIC Investment Corporation
MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection accounts for close to majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia and New York.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.